Sentence: This Nordic multicenter phase II study evaluated the efficacy and safety of oxaliplatin combined with the Nordic bolus schedule of fluorouracil ( FU ) and folinic acid ( FA ) as first-line treatment in metastatic colorectal cancer .
Drug combination annotation:
[{'class': 'POS', 'spans': ['oxaliplatin', 'fluorouracil', 'folinic acid'], 'is_context_needed': True}]